Immuno Aktiengesellschaft

Baxter Aktiengesellschaft

Immuno Aktiengesllschaft

Greenovation Biotech Gmbh

Meridian Biopharmaceuticals Gmbh

Gerda Redl

Peter Turecek

Hans-Peter Schwarz

Johann J Eibl

Thomas Seelich

Gunter Wober

Gabriela Hummel

Eugen Stermetz

Andreas Hauer

Hellmut Samonigg

The invention relates to a pharmaceutical composition for the treatment of patients with blood coagulation diseases which are caused by coagulation factor deficiency and/or inhibitors of coagulation factors, whereby the composition as a FEIB-activity and is characterized in that it has Factor VIIa and at least one further active ingredient and the activity of at least 10 Factor VIIa units per unit FEIBA. Additionally, the invention comprises a method for the production of the pharmaceutical preparation and its use.

Pharmaceutical composition for the treatment of blood coagulation

The invention relates to a pharmaceutical composition for the treatment of patients with blood coagulation diseases which are caused by coagulation factor deficiency and/or inhibitors of coagulation factors, whereby the composition has a FEIB-activity and is characterized in that it has Factor VIIa and at least one further active ingredient and the activity of at least 10 Factor VIIa units per unit FEIBA. Additionally, the invention comprises a method for the production of the pharmaceutical preparation and its use.

In a method of producing a virus-safe biological preparation by heating while preserving a least 50% of its biologic activity, a biologially compatible tenside is added to the preparation before heating and heating is carried out in the presence of the same, whereupon the tenside, preferably, is eliminated.

Method of producing a virus-safe biological preparation

Growing community of inventors

Rutzendorf, Austria

Gerda Redl